Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1585 of 5804
-
Molecular map may guide treatment for mysterious inflammatory illnesses
Disease control CompletedInflammatory diseases may display atypical features making such patients impossible to classify. Management of these cases in daily practice cannot rely on the results of clinical trials nor on guidelines. DNA and RNA mapping have become major tools to understand and sometimes di…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Lifestyle coaching may ward off depression in widowed seniors
Prevention CompletedUsing an indicated prevention approach, investigators propose to enroll 150 spousally-bereaved adults aged 60 years and older in the first 12 months after spousal death who are at high risk for major depression disorder because of subthreshold symptoms of depression. A confirmato…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New grass allergy shot shows promise in reducing hay fever misery
Symptom relief CompletedPQGrass309 is aimed at exploring the expected average treatment effect of PQ Grass 27600 SU cumulative dose on symptom and medication score in a field setting. The study will enrol adult subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis (SAR) induced by grass po…
Phase: PHASE2, PHASE3 • Sponsor: Allergy Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Smart ventilator trial: can automation cut ICU breathing time?
Disease control CompletedINTELLiVENT-Adaptive Support Ventilation (ASV) is a fully automated closed-loop mode of mechanical ventilation available on commercial ventilators. Evidence for clinical benefit of INTELLiVENT-ASV in comparison to non-automated ventilation is lacking. The ACTiVE study is an inte…
Phase: NA • Sponsor: Prof. Dr. Marcus J. Schultz • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy aims to outsmart tough leukemia
Disease control Recruiting nowThis research study is studying a combination of drugs as a possible treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The names of the study drugs involved in this study are: * obinutuzumab * venetoclax * acalabrutinib
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
MS patients may ditch IV drips for At-Home shots
Disease control CompletedA single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis who are transitioning from aCD20 mAb therapy
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug aims to save hearts in duchenne muscular dystrophy
Disease control CompletedDuchenne muscular dystrophy (DMD) is a devastating X-linked disease which leads to loss of ambulation between ages 7 and 13, respiratory failure and cardiomyopathy (CM) at any age, and inevitably premature death of affected young men in their late twenties. DMD is the most common…
Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Stem cells aim to restore sexual function after prostate cancer surgery
Disease control CompletedThis phase II clinical trial is designed to evaluate the efficacy and safety of autologous Mesenchymal Stem Cells (MSC) injected intracavernously.
Phase: PHASE2 • Sponsor: Pharmicell Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Promising drug shows hope for Hard-to-Treat prostate cancer
Disease control CompletedThis study is designed to evaluate the initial safety and effectiveness of an investigational drug, niraparib, given to patients who have recently received platinum-based chemotherapy for the treatment of prostate cancer. The study enrolls participants with history of advanced pr…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Laser zaps tiny thyroid tumors, no scalpel needed
Disease control OngoingThe purpose of this study is to explore whether percutaneous laser ablation (PLA) is a safe and effective alternative to removing papillary thyroid microcarcinoma (PTMC) with surgery.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Promising pancreatic cancer combo trial halted early
Disease control TerminatedThe purpose of this Phase II study is to assess the efficacy and safety of NIS793 with and without spartalizumab in combination with gemcitabine/nab-paclitaxel versus gemcitabine/nab-paclitaxel in previously untreated mPDAC.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Blood pressure drug may shield young cancer patients from crippling bone disease
Prevention CompletedThis is a randomized unblinded Phase II clinical trial evaluating the impact of intensive antihypertensive control (targeted to the 50-75th percentile for age, sex, and height) compared to conventional antihypertensive control (targeted to the 90-95th percentile for age, sex, and…
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Could a personalized probiotic ease autism symptoms?
Symptom relief CompletedThis is a study of the effect of a customized probiotic on children and adults with autism, including effects on autism symptoms and gastrointestinal symptoms.
Phase: NA • Sponsor: Arizona State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Promising drug may shrink brain tumors in relapsed lymphoma
Disease control OngoingThe purpose of this study is to test whether giving acalabrutinib is safe and effective in controlling relapsed central nervous system (CNS) lymphoma. Currently, there are no FDA-approved treatments for relapsed CNS lymphoma. Although acalabrutinib has not been approved for the t…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Triple threat: new drug cocktail targets BRCA breast cancer
Disease control CompletedThe main purpose of this research study is to learn whether the investigational combination of olaparib, palbociclib, and fulvestrant is safe in patients with estrogen receptor-positive breast cancer and BRCA1 or BRCA2 mutations.
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Blood test aims to catch hidden head and neck cancer early
Knowledge-focused OngoingThis research study will include patients with high risk locally advanced head and neck squamous cell carcinoma (LA-HNSCC) of the oral cavity, oropharynx, hypopharynx or larynx and patients that are starting on standard definitive treatment. Patients with both stage III HPV posit…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Could MRI replace CT for sharper cancer radiation planning?
Disease control Recruiting nowThis is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Heart stent study: can ultrasound cut repeat procedures?
Disease control OngoingIntravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) has been shown in clinical trials, registries, and meta-analyses to reduce recurrent events after PCI. This is accomplished by improving the angiographic result with lesion and vessel assessment to gu…
Phase: NA • Sponsor: Medstar Health Research Institute • Aim: Disease control
Last updated Jun 26, 2026 15:58 UTC
-
New cocktail of drugs aimed at halting bone metastases in prostate cancer
Disease control TerminatedThis phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in treating patients with castrate-resistant prostate cancer that had spread to other places in the body (m…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Acupuncture with a jolt: new hope for shingles nerve pain?
Symptom relief CompletedThe investigators designed the multicenter randomized parallel controlled clinical trial of electroacupuncture on PHN which is rigorously designed and have an appropriate sample size, aiming to evaluate the efficacy and safety of electroacupuncture in pain relieving and pain remo…
Phase: NA • Sponsor: Nanjing University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC